Your browser doesn't support javascript.
loading
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial.
Zhu, Feng-Cai; Hu, Shang-Ying; Hong, Ying; Hu, Yue-Mei; Zhang, Xun; Zhang, Yi-Ju; Pan, Qin-Jing; Zhang, Wen-Hua; Zhao, Fang-Hui; Zhang, Cheng-Fu; Yang, Xiaoping; Yu, Jia-Xi; Zhu, Jiahong; Zhu, Yejiang; Chen, Feng; Zhang, Qian; Wang, Hong; Wang, Changrong; Bi, Jun; Xue, Shiyin; Shen, Lingling; Zhang, Yan-Shu; He, Yunkun; Tang, Haiwen; Karkada, Naveen; Suryakiran, Pemmaraju; Bi, Dan; Struyf, Frank.
Afiliación
  • Zhu FC; Jiangsu Province Center for Disease Prevention and Control, Nanjing, China.
  • Hu SY; National Cancer Center - Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China.
  • Hong Y; Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Hu YM; Jiangsu Province Center for Disease Prevention and Control, Nanjing, China.
  • Zhang X; National Cancer Center - Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China.
  • Zhang YJ; Jiangsu Province Center for Disease Prevention and Control, Nanjing, China.
  • Pan QJ; National Cancer Center - Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China.
  • Zhang WH; National Cancer Center - Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China.
  • Zhao FH; National Cancer Center - Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China.
  • Zhang CF; Lianshui Center for Disease Prevention and Control, Lianshui, China.
  • Yang X; Jintan Center for Disease Prevention and Control, Jintan, China.
  • Yu JX; Xuzhou Center for Disease Prevention and Control, Xuzhou, China.
  • Zhu J; Lianshui Center for Disease Prevention and Control, Lianshui, China.
  • Zhu Y; Binhai Center for Disease Prevention and Control, Yancheng, China.
  • Chen F; National Cancer Center - Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China.
  • Zhang Q; National Cancer Center - Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China.
  • Wang H; National Cancer Center - Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China.
  • Wang C; Jintan Center for Disease Prevention and Control, Jintan, China.
  • Bi J; Xuzhou Center for Disease Prevention and Control, Xuzhou, China.
  • Xue S; Lianshui Center for Disease Prevention and Control, Lianshui, China.
  • Shen L; Xuzhou Center for Disease Prevention and Control, Xuzhou, China.
  • Zhang YS; Binhai Center for Disease Prevention and Control, Yancheng, China.
  • He Y; GSK, Shanghai, China.
  • Tang H; GSK, Shanghai, China.
  • Karkada N; GSK, Bangalore, India.
  • Suryakiran P; GSK, Bangalore, India.
  • Bi D; GSK, Wavre, Belgium.
  • Struyf F; GSK, Wavre, Belgium.
Cancer Med ; 8(14): 6195-6211, 2019 10.
Article en En | MEDLINE | ID: mdl-31305011
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Papillomavirus Humano 16 / Papillomavirus Humano 18 / Vacunas contra Papillomavirus / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Med Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Papillomavirus Humano 16 / Papillomavirus Humano 18 / Vacunas contra Papillomavirus / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Med Año: 2019 Tipo del documento: Article País de afiliación: China